| Aqueous solubility of compound at pH 7.4 - BioAssay Summary Based on a high-throughput screen, cyclopentanecarboxanilides were identified as a new chemotype of non-covalent inhibitors of type I fatty acid synthase (FAS). Starting from initial hits we aimed at generating a tool compound suitable for the in vivo validation of FAS as a therapeutic target. Optimisation yielded BI 99179 which is characterised by high potency, remarkably high selectivity and significant exposure (both peripheral and central) upon oral administration in rats. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
Tested Compound: Description: Title: Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure. Abstract: Based on a high-throughput screen, cyclopentanecarboxanilides were identified as a new chemotype of non-covalent inhibitors of type I fatty acid synthase (FAS). Starting from initial hits we aimed at generating a tool compound suitable for the in vivo validation of FAS as a therapeutic target. Optimisation yielded BI 99179 which is characterised by high potency, remarkably high selectivity and significant exposure (both peripheral and central) upon oral administration in rats. (PMID: 21873051) Comment Putative Target: ChEMBL Target ID: 22226 Target Type: UNCHECKED Pref Name: Unchecked Confidence: Default value - Target unknown or has yet to be assigned Relationship Type: Default value - Target has yet to be curated Categorized Comment ChEMBL Assay Type: Unassigned ChEMBL Assay Data Source: Scientific Literature Result Definitions
Data Table (Concise)
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||